In this study, we will be doing skin and blood tests on people with and without a history of eczema (atopic dermatitis). We will also do these tests on people with and without a history of using the eczema drug called Dupixent. We hope to discover new genes, proteins, and fats that might lead to eczema being more or less serious and eczema treatments working better or worse in certain people.
At each visit, you will meet with a study team member and fill out questionnaires about your eczema. We will also use tape and skin swabs to gently remove some of your skin cells. The study also involves blood draws, photographs of your eczema, vital signs, and an optional biopsy of your skin, for which you would receive extra compensation.
$45-95 per visit, plus $100-200 per optional biopsy, , Dermatological care of eczema, including the possibility of receiving Dupixent, a normally expensive biologic medication
Dermatology Clinical Trials Unit (DCTU)
UNC Dermatology and Skin Cancer Center at Southern Village
410 Market St Ste 362, Chapel Hill, NC 27516, USA
Aída Lugo-Somolinos
Dermatology - Adult
Clinical or Medical
Interventional
Allergy
Healthy Volunteer or General Population
Skin, Hair, and Nails
22-1668
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
